Total Products under this Category: 119
Last updated: September 05, 2026
Why You Can Trust G2's Software Rankings:
G2's software rankings are built on verified user reviews, rigorous moderation, and a consistent research methodology maintained by a team of analysts and data experts. Each product is measured using the same transparent criteria, with no paid placement or vendor influence. While reviews reflect real user experiences, which can be subjective, they offer valuable insight into how software performs in the hands of professionals. Together, these inputs power the G2 Score, a standardized way to compare tools within every category.
Highlighted products: Google Cloud Deep Learning VM Image, Google Cloud Deep Learning Containers, AWS Deep Learning AMIs, AIToolbox, Microsoft Cognitive Toolkit (Formerly CNTK), Knet, Merlin, and ConvNetJS.
Underlying data: [Grid® JSON](https://www.g2.com/categories/artificial-neural-network/grids.json?focus%5B%5D=google-cloud-deep-learning-vm-image&focus%5B%5D=google-cloud-deep-learning-containers&focus%5B%5D=aws-deep-learning-amis&focus%5B%5D=aitoolbox&focus%5B%5D=microsoft-cognitive-toolkit-formerly-cntk&focus%5B%5D=knet&focus%5B%5D=merlin&focus%5B%5D=convnetjs)
OmniML is an enterprise artificial intelligence (AI) company that aims to effortlessly empower AI everywhere.
Average Rating: 3.0/5.0
Total Reviews: 1
Easy and Blazing fast procurement, command and control for AI compute.
Average Rating: 5.0/5.0
Total Reviews: 1
Rating: 5.0/5.0 stars
— Anusha R.
Build Applications with Fully Homomorphic Encryption (FHE). Zama is an open source cryptography company building state-of-the-art FHE solutions for blockchain and AI.
Average Rating: 4.0/5.0
Total Reviews: 1
Rating: 4.0/5.0 stars
— Roberto S.
Accord.NET Framework is a .NET machine learning framework combined with audio and image processing libraries completely written in C#, it is a framework for building production-grade computer vision, computer audition, signal processing and statistics applications even for commercial use
Average Rating: 5.0/5.0
Total Reviews: 1
Rating: 5.0/5.0 stars
— gahungu J.
aiMotive is a leading automotive technology company specializing in automated driving solutions. Their integrated product portfolio includes aiData, aiSim, and aiWare, designed to enable OEMs to develop and deploy scalable automated driving features efficiently. By combining advanced data tools with embedded solutions, aiMotive helps reduce development costs and accelerate time-to-market for automotive players. Key Features and Functionality: - aiData: A comprehensive data pipeline that automates data collection, annotation, and synthetic training data generation, ensuring high-quality datasets for developing safe automated driving solutions. - aiSim: A virtual validation suite offering scalable, high-fidelity sensor and environment simulation for real-time testing, facilitating the validation of complex automated driving systems from concept to production. - aiWare: A high-performance neural processing unit (NPU) IP core delivering up to 98% efficiency for a wide range of automotive neural networks, designed for power-efficient, low-latency AI inference in automotive applications. Primary Value and User Solutions: aiMotive's solutions address the critical challenges in automated driving development by providing an end-to-end toolchain that enhances data processing, simulation, and AI inference capabilities. This holistic approach enables automotive manufacturers to bridge technology gaps, reduce development costs, and accelerate the deployment of advanced driver-assistance systems (ADAS) and autonomous driving features, ultimately contributing to safer and more efficient vehicles on the road.
Apache SINGA is an Apache Top Level Project, focusing on distributed training of deep learning and machine learning models
The Asimov Institute is a non-profit AI research organization dedicated to exploring the intersection of deep learning and creativity. By publishing fundamental breakthroughs in neural network research and developing tools for the creative industry—including architects, graphic designers, fashion designers, marketers, and music producers—the institute aims to harness automated novelty as a valuable asset across various sectors. Their neural networks are designed to generate new products, content, styles, and ideas, thereby pushing the boundaries of artificial creativity. Key Features and Functionality: - Neural Network Research: Conducts in-depth studies on neural network architectures and their applications in creative processes. - Creative Industry Tools: Develops AI-driven tools tailored for professionals in architecture, graphic design, fashion, marketing, and music production. - Automated Content Generation: Utilizes neural networks to produce innovative products, content, styles, and ideas, enhancing creative workflows. - Educational Resources: Provides insights and publications on neural network architectures, such as the "Neural Network Zoo," to educate and inform the AI community. Primary Value and Solutions: The Asimov Institute addresses the growing need for innovation in the creative industry by integrating deep learning technologies into creative processes. By automating the generation of novel content and ideas, the institute empowers professionals to overcome creative constraints, streamline their workflows, and explore new artistic possibilities. This fusion of AI and creativity not only enhances productivity but also opens up new avenues for artistic expression and design.
Atomwise is a technology-driven pharmaceutical company that leverages artificial intelligence (AI) to revolutionize small molecule drug discovery. By pioneering the use of deep learning for structure-based drug design, Atomwise has developed a best-in-class AI discovery engine capable of identifying and optimizing novel chemical compounds. This innovative approach has been extensively validated, demonstrating the ability to discover compounds with therapeutic potential across a diverse range of protein types and numerous challenging targets. Atomwise is advancing a proprietary pipeline of small-molecule drug candidates, aiming to transform the drug discovery process and deliver better medicines to patients more efficiently. Key Features and Functionality: - AtomNet® Technology: The first deep convolutional neural network designed for drug discovery, capable of screening over 16 billion compounds in less than two days. - Extensive Validation: Demonstrated success in over 185 projects, including a wide variety of protein types and numerous "hard-to-drug" targets. - Collaborative Partnerships: Engaged in over 775 collaborations with more than 250 partners worldwide, addressing over 600 unique disease targets. - Proprietary Pipeline: Developing a pipeline of small-molecule drug candidates advancing into preclinical studies. Primary Value and Problem Solved: Atomwise addresses the inefficiencies and limitations of traditional drug discovery methods by integrating AI and deep learning into the process. This approach enables the rapid and accurate identification of potential drug candidates, significantly reducing the time and resources required for hit discovery, lead optimization, and toxicity predictions. By overcoming physical barriers and expanding the chemical space for screening, Atomwise enhances the likelihood of discovering effective and safe therapeutics, ultimately accelerating the development of better medicines for patients.
Avey AI C-Suite is a comprehensive suite of AI-driven tools designed to enhance healthcare delivery by providing instant diagnostic support, recommending care plans, automating clinical documentation, and accurately coding medical concepts. Tailored for healthcare providers, this suite integrates seamlessly into existing workflows, empowering physicians with clinical-grade AI capabilities to improve patient outcomes and operational efficiency. Key Features and Functionality: - Diagnostic Support: Offers real-time assistance in diagnosing medical conditions, aiding physicians in making accurate and timely decisions. - Care Plan Recommendations: Suggests personalized care plans based on patient data, ensuring evidence-based treatment approaches. - Automated Documentation: Streamlines the creation of clinical notes and reports, reducing administrative burdens and allowing more focus on patient care. - Medical Coding: Accurately codes medical concepts, facilitating precise billing and compliance with healthcare regulations. Primary Value and Solutions Provided: Avey AI C-Suite addresses several critical challenges in the healthcare sector: - Enhanced Diagnostic Accuracy: By providing instant diagnostic support, it reduces the likelihood of errors and improves patient safety. - Operational Efficiency: Automating documentation and coding processes minimizes administrative tasks, allowing healthcare professionals to dedicate more time to patient care. - Compliance and Precision: Ensures accurate medical coding, which is essential for proper billing and adherence to healthcare standards. By integrating Avey AI C-Suite into their practices, healthcare providers can achieve higher efficiency, accuracy, and improved patient outcomes.
BigDL makes it easier for data scientists and data engineers to build end-to-end, distributed AI applications.
BIOS Health is a pioneering neurotechnology company that leverages artificial intelligence (AI) and advanced neural interfaces to decode and modulate the body's neural signals. By translating the complex 'code' of the nervous system, BIOS Health aims to develop precise, data-driven therapies for a range of chronic conditions, including cardiovascular diseases, diabetes, and neurodegenerative disorders. Key Features and Functionality: - Real-Time Neural Insights: Utilizing proprietary neural interfaces combined with AI, BIOS Health can measure and analyze neural data in real-time across both acute and chronic settings. - Neural Biomarkers Discovery: The company has developed a programming language for the nervous system, enabling the identification of novel neural biomarkers that can lead to groundbreaking disease insights and innovative treatments. - Precision Health Solutions: By harnessing real-time feedback from the nervous system, BIOS Health facilitates the creation of more targeted pharmaceuticals and software-delivered therapies, enhancing treatment efficacy and patient outcomes. Primary Value and User Solutions: BIOS Health addresses the critical need for personalized and effective treatments for chronic diseases by providing a platform that interprets and interacts with neural data. This approach allows for the development of therapies that are tailored to individual neural profiles, potentially improving the quality of life for millions of patients worldwide. By bridging the gap between neural data and therapeutic interventions, BIOS Health is at the forefront of a new era in precision medicine.
BrainKey is an innovative platform that leverages artificial intelligence to analyze brain MRI scans, providing personalized insights into brain health. By transforming complex medical imaging data into clear, intuitive visualizations, BrainKey empowers individuals and healthcare professionals to better understand and monitor neurological well-being. Key Features and Functionality: - AI-Powered Analysis: Utilizes advanced AI algorithms to examine MRI scans, identifying key biomarkers and assessing brain health at a biological level. - Personalized Visualizations: Converts intricate brain imaging data into user-friendly, interactive visual representations of individual brain anatomy. - 3D Brain Printing: Offers a unique service to create a 3D-printed model of a user's brain, based on their MRI scan, providing a tangible representation of their brain structure. Primary Value and User Solutions: BrainKey addresses the challenge of interpreting complex neurological data by making brain health information more accessible and understandable. This empowers users to take proactive steps in managing their cognitive health, facilitates early detection of potential issues, and supports healthcare providers in delivering personalized care. By demystifying brain imaging, BrainKey aims to prevent cognitive decline and contribute to a future where conditions like dementia are no longer prevalent.
